Difference between revisions of "Team:IISc Bangalore"
Prabaha007 (Talk | contribs) |
Prabaha007 (Talk | contribs) |
||
| Line 66: | Line 66: | ||
<li class="active hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore">Home</a></li> | <li class="active hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore">Home</a></li> | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Team">Team</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Team">Team</a></li> | ||
| − | + | ||
<li class="dropdown"><a class="dropdown-toggle" data-toggle="dropdown" href="#">Project </a> | <li class="dropdown"><a class="dropdown-toggle" data-toggle="dropdown" href="#">Project </a> | ||
| Line 73: | Line 73: | ||
<li><a href="https://2016.igem.org/Team:IISc_Bangalore/Experiments">Experiments</a></li> | <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Experiments">Experiments</a></li> | ||
<li><a href="https://2016.igem.org/Team:IISc_Bangalore/Results">Results</a></li> | <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Results">Results</a></li> | ||
| + | <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Notebook">Notebook</a></li> | ||
| + | <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Safety">Safety</a></li> | ||
</ul> | </ul> | ||
</li> | </li> | ||
| − | + | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Parts">Parts</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Parts">Parts</a></li> | ||
| − | + | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Collaborations">Collaborations</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Collaborations">Collaborations</a></li> | ||
<li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Attributions">Attributions</a></li> | <li class="hvr-underline-from-left"><a href="https://2016.igem.org/Team:IISc_Bangalore/Attributions">Attributions</a></li> | ||
| Line 91: | Line 93: | ||
<li><a href="https://2016.igem.org/Team:IISc_Bangalore/Entrepreneurship">Entrepreneurship</a></li> | <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Entrepreneurship">Entrepreneurship</a></li> | ||
<li><a href="https://2016.igem.org/Team:IISc_Bangalore/Design">Applied Design</a></li> | <li><a href="https://2016.igem.org/Team:IISc_Bangalore/Design">Applied Design</a></li> | ||
| − | </ul> | + | </ul> |
| − | </li> | + | </li> |
</ul> | </ul> | ||
| Line 230: | Line 232: | ||
</div> | </div> | ||
</html> | </html> | ||
| − | [[File: | + | [[File:Team3iisc.jpeg|center|500px|From left: Abhijeet, Prabaha, Aiswarya, Shreyas, Arunavo, Srinath Sir]] |
<html> | <html> | ||
Revision as of 00:42, 20 October 2016
Cellfiefuge
Overview
With the advent of rDNA technology in the late 1970s, medicine, agriculture and several other areas underwent a quantum leap and from that point, progress only hastened, from one only one recombinant pharmaceutical approved for human use (insulin) in 1982 to one hundred and fifty-one FDA approved protein based recombinant pharmaceuticals by 2009[1].
Read more
